Nurix Therapeutics (NRIX) Selling, General & Administrative (2019 - 2026)
Nurix Therapeutics' Selling, General & Administrative came in at $34.35 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 161.1% from $13.16 million a year earlier and up 120.3% from the prior quarter.
Nurix Therapeutics (NRIX) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Aug 31, 2026, Nurix Therapeutics reported Selling, General & Administrative of $78.21 million, up 57.0% year-over-year; for FY2025 (ended Nov 30, 2025), it was $52.74 million, up 14.8% from FY2024.
- Selling, General & Administrative has increased in each of the last six fiscal years, with a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
- Going back by fiscal year, Selling, General & Administrative was $45.94 million in FY2024 (+7.1%), $42.9 million in FY2023 (+12.9%), $38 million in FY2022 (+21.8%) and $31.2 million in FY2021 (+91.3%).
- The fiscal Q3 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to fiscal Q3 2019.
- Year-over-year, Selling, General & Administrative has increased for six consecutive quarters, with growth averaging 31.9% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in fiscal Q3 2026 (growth of 161.1%), and the weakest in fiscal Q1 2025 (a decline of 1.2%).
- Business Quant data shows NRIX's Selling, General & Administrative at $15.59 million (Q2 2026), $14.61 million (Q1 2026) and $13.65 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 34.35 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 34.35 Mn |
| May 31, 2026 | 15.59 Mn |
| Feb 28, 2026 | 14.61 Mn |
| Nov 30, 2025 | 13.65 Mn |
| Aug 31, 2025 | 13.16 Mn |
| May 31, 2025 | 14.28 Mn |
| Feb 28, 2025 | 11.65 Mn |
| Nov 30, 2024 | 10.72 Mn |
| Aug 31, 2024 | 11.72 Mn |
| May 31, 2024 | 11.71 Mn |
| Feb 29, 2024 | 11.80 Mn |
| Nov 30, 2023 | 10.78 Mn |
| Aug 31, 2023 | 10.62 Mn |
| May 31, 2023 | 11.68 Mn |
| Feb 28, 2023 | 9.82 Mn |
| Nov 30, 2022 | 9.37 Mn |
| Aug 31, 2022 | 9.75 Mn |
| May 31, 2022 | 9.65 Mn |
| Feb 28, 2022 | 9.23 Mn |
| Nov 30, 2021 | 8.82 Mn |
Nurix Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();